Skip to main content

Table 1 Means and (SD) of patients’ characteristics at baseline

From: Fampridine and quality of life in individuals with multiple sclerosis

Patients’ characteristics All patients (n = 50) Non-respondent (n = 35) Respondent (n = 15) p
Age (years) 51.4 (11.7) 49.2 (10.9) 55.5 (12.3) 0.06
Gender (m/f %) 32/68 30/70 35/65 0.45
EDSS 5.2 (1.1) 5 (1.0) 5.8 (1.1) 0.01
Height (m) 1.67 (0.09) 1.67 (0.09) 1.66 (0.08) 0.66
Body mass (kg) 75.5 (17.2) 73.1 (16.9) 80.12 (17.4) 0.17
BMI (kg m−2) 27 (5.7) 26 (5.7) 28.9 (5.5) 0.09
Disease duration (years) 14.3 (9.3) 13.5 (8.5) 16.2 (11) 0.36
MS type (RR–SP–PP %) 22–48–32 22–49–29 13–47–40 0.22
  1. The italic value correspond statistical significant differences
  2. EDSS expanded disability status scale, BMI body mass index, RR relapsing–remitting, SP secondary progressive, PP primary progressive